ABBVIE INC. (ABBV) Dividend History

AbbVie Inc. (ABBV) is a global biopharmaceutical company founded in 2013 as a spin-off from Abbott Laboratories. It specializes in the research, development, and marketing of innovative medicines across a range of therapeutic areas, including immunology, oncology, virology, and neuroscience. AbbVie is known for its flagship product, Humira, a leading treatment for autoimmune diseases. The company focuses on advancing scientific discoveries to deliver novel therapies and improve patient outcomes worldwide.

1 North Waukegan Road, North Chicago, IL, 60064
Phone: (847) 932-7900
Website: http://www.abbvieinvestor.com

Dividend Yield: 3.37%

Dividend Frequency: Quarterly

Dividend History

Pay Date	Amount	Ex Dividend Date	Record Date
August 15, 2025	$1.64	07/15/2025	07/15/2025
May 15, 2025	$1.64	04/15/2025	04/15/2025
February 14, 2025	$1.64	01/15/2025	01/15/2025
November 15, 2024	$1.55	10/15/2024	10/15/2024
August 15, 2024	$1.55	07/15/2024	07/15/2024
May 15, 2024	$1.55	04/12/2024	04/15/2024
February 15, 2024	$1.55	01/12/2024	01/16/2024
November 15, 2023	$1.48	10/12/2023	10/13/2023
August 15, 2023	$1.48	07/13/2023	07/14/2023
May 15, 2023	$1.48	04/13/2023	04/14/2023
February 15, 2023	$1.48	01/12/2023	01/13/2023
November 15, 2022	$1.41	10/13/2022	10/14/2022
August 15, 2022	$1.41	07/14/2022	07/15/2022
May 16, 2022	$1.41	04/13/2022	04/15/2022
February 15, 2022	$1.41	01/13/2022	01/14/2022
November 15, 2021	$1.30	10/14/2021	10/15/2021
August 16, 2021	$1.30	07/14/2021	07/15/2021
May 14, 2021	$1.30	04/14/2021	04/15/2021
February 16, 2021	$1.30	01/14/2021	01/15/2021
November 16, 2020	$1.18	10/14/2020	10/15/2020
August 14, 2020	$1.18	07/14/2020	07/15/2020
May 15, 2020	$1.18	04/14/2020	04/15/2020
February 14, 2020	$1.18	01/14/2020	01/15/2020
November 15, 2019	$1.07	10/11/2019	10/15/2019
August 15, 2019	$1.07	07/12/2019	07/15/2019
May 15, 2019	$1.07	04/12/2019	04/15/2019
February 15, 2019	$1.07	01/14/2019	01/15/2019
November 15, 2018	$0.96	10/12/2018	10/15/2018
August 15, 2018	$0.96	07/12/2018	07/13/2018
May 15, 2018	$0.96	04/12/2018	04/13/2018
February 15, 2018	$0.71	01/11/2018	01/12/2018
November 15, 2017	$0.64	10/12/2017	10/13/2017
August 15, 2017	$0.64	07/12/2017	07/14/2017
May 15, 2017	$0.64	04/11/2017	04/13/2017
February 15, 2017	$0.64	01/11/2017	01/13/2017
November 15, 2016	$0.57	10/12/2016	10/14/2016
August 15, 2016	$0.57	07/13/2016	07/15/2016
May 16, 2016	$0.57	04/13/2016	04/15/2016
February 16, 2016	$0.57	01/13/2016	01/15/2016
November 14, 2015	$0.51	10/13/2015	10/15/2015
August 14, 2015	$0.51	07/13/2015	07/15/2015
May 15, 2015	$0.51	04/13/2015	04/15/2015
February 13, 2015	$0.49	01/13/2015	01/15/2015
November 17, 2014	$0.42	10/10/2014	10/15/2014
August 15, 2014	$0.42	07/11/2014	07/15/2014
May 15, 2014	$0.42	04/11/2014	04/15/2014
February 14, 2014	$0.40	01/13/2014	01/15/2014
November 15, 2013	$0.40	10/10/2013	10/15/2013
August 15, 2013	$0.40	07/11/2013	07/15/2013
May 15, 2013	$0.40	04/11/2013	04/15/2013
February 15, 2013	$0.40	01/11/2013	01/15/2013

Dividends Summary

ABBVIE INC. has issued 51 dividend payments over the past 12 years
The most recent dividend was paid 51 days ago, on May 15, 2025
The first recorded dividend was paid on February 15, 2013
The highest dividend payout was $1.64 per share
The average dividend over this 12 year span is $0.99 per share
ABBVIE INC. has increased its dividend payments by 310.00% since 2013

Company News

Novartis' Cosentyx Fails Late-Stage Giant Cell Arteritis Trial

Novartis' drug Cosentyx did not demonstrate statistically significant improvement in sustained remission for giant cell arteritis in a Phase 3 trial, despite showing some numerically better outcomes in steroid dose and toxicity compared to placebo.

Benzinga
Questex’s Fierce Pharma Unveils Powerhouse Conference Program for the Inaugural Fierce Pharma Week, Where Pharma’s Future Takes Shape

Questex's Fierce Pharma Week, a premier gathering for pharmaceutical industry leaders, will take place in September 2025 in Philadelphia. The event will feature keynotes, panels, and case studies with thought leaders from major pharmaceutical companies, addressing critical industry challenges and best practices.

GlobeNewswire Inc.
U.S. Pharmaceutical Imports Might Soon Face Tariffs: 3 Stocks That Could Tumble as a Result

The U.S. government is considering imposing tariffs on imported pharmaceuticals, which could negatively impact several major drug companies that rely on overseas manufacturing, including Amgen, Pfizer, and AbbVie.

The Motley Fool

Featured Companies: AMGN PFE
3 Stocks That Missed on Earnings, but Are Set to Rebound Next Quarter

Three companies - Eli Lilly, AbbVie, and Las Vegas Sands - reported lower-than-expected earnings, but analysts believe they are poised for a rebound in the next quarter due to strong product pipelines and market demand.

Investing.com

Featured Companies: LLY LVS

Page data last updated 07/05/2025 01:48:02 UTC Dividend yield is calculated using only dividends that have already been paid. Future or declared dividends are not included

ABBVIE INC. (ABBV) Dividend History

Dividend History

Dividends Summary

Company News

Related Companies